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ABSTRACT: Bone proteomic studies using animal proxies and
skeletonized human remains have delivered encouraging results in
the search for potential biomarkers for precise and accurate post-
mortem interval (PMI) and the age-at-death (AAD) estimation in
medico-legal investigations. The development of forensic proteo-
mics for PMI and AAD estimation is in critical need of research on
human remains throughout decomposition, as currently the effects
of both inter-individual biological differences and taphonomic
alteration on the survival of human bone protein profiles are
unclear. This study investigated the human bone proteome in four
human body donors studied throughout decomposition outdoors.
The effects of ageing phenomena (in vivo and post-mortem) and
intrinsic and extrinsic variables on the variety and abundancy of the
bone proteome were assessed. Results indicate that taphonomic and biological variables play a significant role in the survival of
proteins in bone. Our findings suggest that inter-individual and inter-skeletal differences in bone mineral density (BMD) are
important variables affecting the survival of proteins. Specific proteins survive better within the mineral matrix due to their mineral-
binding properties. The mineral matrix likely also protects these proteins by restricting the movement of decomposer microbes. New
potential biomarkers for PMI estimation and AAD estimation were identified. Future development of forensic bone proteomics
should include standard measurement of BMD and target a combination of different biomarkers.
KEYWORDS: forensic proteomics, forensic taphonomy, bone mineral density, post-mortem interval estimation, age-at-death estimation,
human decomposition, forensic microbiology
1. INTRODUCTION
Estimations of the time elapsed since death (post-mortem
interval, PMI) and the age-at-death (AAD) are crucial in the
forensic investigation of unidentified human remains. This
information is important to distinguish between historical
remains (>100 years old) and remains of medico-legal
relevance (≤100 years old)1,2 and to narrow the search of
missing persons for identification purposes.3,4 High precision,
accuracy, and objectivity of PMI and AAD estimation methods
are essential in order to be considered admissible in a court of
law.
PMI estimation often relies on visual assessment of gross
morphological changes of the body during decomposition,5−7
even though the rate of these changes is known to be highly
variable.8,9 Accuracy of the PMI estimation decreases as
decomposition progresses, and interobserver reliability differs
depending on the method and the experience of the
researcher.9,10 Biochemical techniques have shown promising
results in the search for a precise and accurate method to
estimate late PMI in human bone; however, these methods are
yet to be validated for use in forensic contexts.11−14
Standard AAD estimation methods are based on the
examination of the morphological characteristics of the
remains15 and require the evaluation of several different
skeletal elements.16 Different methods are applied to juveniles
and adults.17,18 Limitations of these methods include a high
interobserver variability,15 inter- and intra-population varia-
bility with increasing AAD,19 lack of consensus regarding the
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evaluation of the errors,20 poor precision in adult aging in
comparison with juvenile and adolescent aging,4 and the
requirement for remains to be as complete as possible.20
In recent years, bone proteomic methods have been
demonstrated to be highly promising for the development of
precise, accurate, and objective PMI and AAD estimation
methods and require only small samples of bone. Proteins are
thought to be relatively stable in bone and have been
successfully extracted from archaeological21−25 and paleonto-
logical specimens,26−29 making them a promising target for
forensic applications.30 Studies conducted using animal models
(e.g., Sus scrofa and Bos bovid) focused on inter- and intra-
individual comparisons and monitored changes in the bone
proteomes associated with progressing decomposition stages.
These studies revealed inter- and intra-skeletal proteomic
variability31 and identified potential biomarkers for AAD31 and
PMI estimations.32 In addition, the burial environment was
found to affect the proteome recovered from archaeological
specimens.33 However, the development of bone proteomic
methods for forensic science remains impeded by the fact that
it is unknown how representative animal models are for human
specimens. Moreover, it is largely unknown how taphonomic
processes and inter-individual variation (both in vivo and at the
time of death), including underlying health conditions, affect
the survival and extraction of bone protein profiles in humans.
A recent study conducted on human bones, collected from a
cemetery in Southeast Spain, provided promising new insights
on the estimation of broad PMI ranges (5−20 years) in
humans using protein biomarkers in proximal femoral bone.34
The study identified 32 proteins which could be used in
conjunction to discriminate between PMIs greater or smaller
than 12 years.34 The sampled individuals were subjected to
similar taphonomic conditions, and PMIs were greater than 7
years in all but one case. While the study was conducted on a
relatively large sample (n = 40), inter-individual and inter-
skeletal comparison of bone protein profiles at different stages
of decomposition of the body was not possible as only one
skeletal element was available per individual, and bones were
sampled only after decomposition of the soft tissues. For the
further development, and ultimately validation, of forensic
proteomics to estimate PMI, the study of changes in human
bone protein profiles from the fresh stage of decomposition to
the skeletonized stage is crucial.
In this study, we aimed to investigate the effects of
taphonomy and biological variation on the recovery and
variability of the human bone proteome and evaluate potential
avenues to develop a broadly applicable, standardized method
of PMI and AAD estimation in human remains in advanced
state of decomposition.35 The proteomes of anterior midshaft
tibia and iliac crest samples from four body donors of known
AAD (two buried and two placed in an open pit), taken shortly
after death and upon complete skeletonization of the body,
were analyzed to investigate (1) whether the previously
identified potential biomarkers for PMI and AAD are
applicable to human bones with lower PMIs, (2) whether
additional potential biomarkers for PMI/AAD estimation
could be identified, (3) whether the human bone proteome
is subject to inter-skeletal (among different skeletal elements of
the same individual), intra-skeletal (within the same skeletal
element), and inter-individual (within the same skeletal
element among different individuals) variability, and (4) the
role decomposition, depositional environment and taphonomy,
and season play in bone proteome survival.
2. EXPERIMENTAL SECTION
2.1. Body Donations
The body donations of four females aged between 61 and 91
years old were placed unclothed to decompose at the Forensic
Anthropology Research Facility (FARF), the outdoor human
decomposition facility associated with the Forensic Anthro-
pology Center at Texas State University (FACTS), between
April 2015 and March 2018. While the targeted bone proteins
in this study are not thought to differ between males and
females, only post-menopausal female individuals were
included, in order to exclude biological sex and major
hormonal differences as a potential variable from the study.
Two body donations (D2 and D3) were buried with soil in
shallow hand dug pits. Two body donations (D1 and D4) were
placed in pits of similar dimensions, which remained open
throughout the experiment. Open pits were covered with metal
cages to protect the remains from large scavengers. The sample
size in this study reflects general trends in human
decomposition research, in which larger sampleslike those
used in clinical studiescan be difficult to obtain for practical,
logistical, and ethical reasons. While animal analogues such as
pigs can be used to alleviate some limitations associated with
small sample sizes, the study of human cadavers is important
due to biological differences between humans and pigs,
including anatomical differences in the digestive vasculature
and molecular differences in adipose tissue.36
Data on body decomposition and weather were collected
throughout the experiment and can be found in Supporting
Information (Table 1). Additional information on FARF’s
environment can be found in the Supporting Information.
Gross decomposition was quantified using the total body score
method following a study by Megyesi et al.37 Accumulated
degree-days (ADD) were calculated using temperature data
recorded on the facility (Supporting Information, Table 2).
2.2. Bone Sample Collection
Bone samples (ca. 1 cm3) of the anterior midshaft tibia and
iliac crest (left) were collected prior to placement of the fresh
body outside and upon retrieval of the completely skeletonized
remains (right). The midshaft tibia was analyzed in this study
because previous research has shown its great intra-skeletal and
inter-individual proteomic reproducibility.31 The iliac crest was
additionally targeted because this bone has naturally higher
porosity and perfusion (i.e., the circulation of blood through
the tissue) compared to the long bones and because a higher
amount of bacterial infiltration (post-mortem colonization by
gut bacteria) is to be expected in iliac bone due to its proximity
to the intestinal area. Proteomic comparison between two
areas of the skeleton which naturally differ in bone density,
perfusion of the bone, as well as proximity to large bacterial
communities known to play a significant role in early and
advanced decomposition of the body, can offer valuable
insights into the role that both taphonomic and biological
variables play in the survival of the bone proteome throughout
decay. The total of 16 bone samples were stored in sterile
plastic bags and immediately transferred to a lockable freezer at
−80 °C. Samples were shipped overnight on dry ice to the
Forensic Science Unit at Northumbria University, U.K. Upon
arrival, the samples were immediately transferred to a lockable
freezer at −18 °C, adhering to the U.K. Human Tissue Act
under the license number 12495. The experiment was
reviewed and approved by the ethics committee at North-
umbria University, with the reference code 11623. All
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biological and bone sample data are provided in Table 1.
Observations on bone condition (density and color) during
sampling can be found in the Supporting Information.
2.3. Sub-sampling and Sample Preparation
The 16 samples were defrosted prior to their analysis, then
cleaned in deionized water for 3 h at room temperature,
exchanging the water three times, once every hour. They were
then dried in a fume cupboard at room temperature until
completely dry. Bone samples were then secured in a table
clamp for the sampling. Contamination between samples was
prevented by using a double layer of aluminum foil within the
clamp (in contact with the bone) and by using new foil double
layers for each piece of bone sampled. The clamp was also
cleaned in between each sampling step using 50% sodium
hypochlorite (Sigma-Aldrich, U.K.), to further prevent
contamination issues. Once the bone was secured in the
clamp, Dentist’s Protaper Universal Hand Files (Henry Schein
Minerva Dental, U.K.) were used to hand-drill ∼25 mg of fine
bone powder three times (i.e., three samplings were performed
on the same bone fragment), in order to obtain three replicates
for each of the bones analyzed. By sampling in different
locations close together on the same bone, we obtained
multiple biological samples. Since it is known that bone
proteins can vary throughout the human skeleton and within
individual bones, these biological replicates, in contrast to
technical replicates, allow us to assess the degree of intra-bone
variability and to establish whether inter-individual differences
are greater than the intra-bone variability, as indicated in a
previous study using pigs as proxies.31 Protaper files were
changed between each sample, to prevent contamination.
When the bone samples were too porous to obtain a fine bone
powder (e.g., iliac crest samples), small bone fragments were
cut using the Protaper files, and ∼25 mg of bone fragments was
collected for each of the three subsamples in order to have
three replicates.
2.4. Micro Computed Tomography
During sampling of the bone, one of the specimens was
observed to be considerably denser compared to the others.
This difference was investigated non-invasively using micro
computed tomography (μCT), in order to quantify the
difference and to examine any potential relationship with the
proteomic results. Microarchitectural and compositional
properties were examined by means of μCT. Bone specimens
were scanned with a NSI X5000 micro-CT system (North Star
Imaging, Aliso Viejo, California, USA) operated at 79 kV and
0.185 mA. Voxel size was 117.095 μm for Tibia and 51.07 μm
for the Crista Iliaca. BoneJ was employed to quantify certain
material volume (BV) and total volume (TV) for the region of
interest represented by the cortical area above the sampling
area. A QRM-Micro-CT-HA D20 (QRM GmbH, Moehren-
dorf, Germany) calibration phantom was scanned under the
same conditions. The mean gray scale values obtained from the
attenuation histogram were used to fit the calibration curve of
volumetric tissue mineral density (vTMD) gray scale values.
These were employed to calculate vTMD values for the
cortical area under analysis. Furthermore, volumetric bone
mineral density values (vBMD) was calculated according to
the following formula:
vBMD vTMD BV/TV= ·
2.5. Protein Extraction
Overall, 48 samples were obtained from the 16 bone pieces
and subjected to bone protein extraction following the
protocol of Procopio and Buckley.38 Briefly, each sample was
decalcified with 1 mL of 10 v/v % formic acid (Fisher
Scientific, U.K.) for 6 h at 4 °C. After removing all the acid
soluble fraction, the acid insoluble fraction was incubated for
18 h at 4 °C with 500 μL of 6 M guanidine hydrochloride/100
mM TRIS buffer (pH 7.4, Sigma-Aldrich, U.K.). The buffer
was exchanged into 100 μL of 50 mM ammonium acetate
(Scientific Laboratory Supplies, U.K.) with 10K molecular-
weight cut off filters (Vivaspin 500 polyethersulfone, 10 kDa,
Sartorius, Germany), and samples were then reduced with 4.2
μL of 5 mM dithiothreitol (DTT) (Fluorochem, U.K.) for 40
min at room temperature and alkylated with 16.8 μL of 15 mM
iodoacetamide (Sigma-Aldrich, U.K.) for 45 min in the dark at
room temperature. Samples were then quenched with another
4.2 μL of 5 mM DTT, then digested with 0.4 μg of trypsin
(Promega, U.K.) for 5 h at 37 °C, and finally frozen. By adding
15 μL of 1 v/v % trifluoroacetic acid (TFA) (Fluorochem,
U.K.), the digestion was stopped and the samples were then
Table 1. Biological and Bone Sample Data
donor
age at death











1 91 F B1A-2-iliac NP1-2-3 open pit 28-04-2015 28-04-2015 −1
1 91 F B1A-2-tibia NP4-5-6 open pit 28-04-2015 −1
1 91 F B1C-2-iliac NP7-8-9 open pit 03-12-2015 219
1 91 F B1C-2-tibia NP10-11-12 open pit 03-12-2015 219
2 67 F B2A-2-iliac NP13-14-15 burial 07-05-2015 07-05-2015 0
2 67 F B2A-2-tibia NP16-17-18 burial 07-05-2015 0
2 67 F B2C-2-iliac NP19-21-21 burial 17-08-2017 834
2 67 F B2C-2-tibia NP22-23-24 burial 17-08-2017 834
3 61 F B3A-2-iliac NP25-26-27 burial 24-06-2015 24-06-2015 0
3 61 F B3A-2-tibia NP28-29-30 burial 24-06-2015 0
3 61 F B3C-2-iliac NP31-32-33 burial 21-08-2017 790
3 61 F B3C-2-tibia NP34-35-36 burial 21-08-2017 790
4 77 F B4A-2-iliac NP37-38-39 open pit 19-10-2015 19-10-2015 −1
4 77 F B4A-2-tibia NP40-41-42 open pit 19-10-2015 −1
4 77 F B4C-2-iliac NP43-44-45 open pit 09-03-2018 872
4 77 F B4C-2-tibia NP46-47-48 open pit 09-03-2018 872
aT0 = day of burial/placement.
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desalted, concentrated, and purified using OMIX C18 pipette
tips (Agilent Technologies, U.S.A.) with 0.1 v/v % TFA as
washing solution and 50 v/v % acetonitrile (ACN) (Thermo
Fisher Scientific, U.K.)/0.1 v/v % TFA as a conditioning
solution. Pipette tips were prepared with two volumes of 100
μL of 0.1 v/v % TFA and washed twice with 100 μL of 50 v/v
% ACN/0.1 v/v % TFA. The sample was then aspirated into
the tip at least ten times to efficiently bind peptides to the
absorbent membrane. Finally, two washing steps with 100 μL
of 0.1 v/v % TFA were performed, prior to peptides elution
into 100 μL of 50 v/v % ACN/0.1 v/v % TFA. Purified
peptides were left in the fume cupboard at room temperature
with lids open to dry prior to their submission for LC−MS/
MS analysis.
2.6. LC/MS−MS Analysis
Samples resuspended in 5 v/v % ACN/0.1 v/v % TFA were
analyzed by LC−MS/MS using an Ultimate 3000 Rapid
Separation LC (RSLC) nano LC system (Dionex Corporation,
Sunnyvale, CA, USA) coupled to a Q Exactive Plus Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher
Scientific, Waltham, MA, U.S.A.). Peptides were separated
on an EASY-Spray reverse phase LC Column (500 mm × 75
μm diameter (i.d.), 2 μm, Thermo Fisher Scientific, Waltham,
MA, USA) using a gradient from 96 v/v % A (0.1 v/v % FA in
5 v/v % ACN) and 4 v/v % B (0.1 v/v % FA in 95 v/v %
ACN) to 8 v/v %, 30 v/v %, and 50% B at 14, 50, and 60 min,
respectively, at a flow rate of 300 nL min−1. Acclaim PepMap
100 C18 LC Column (5 mm × 0.3 mm i.d., 5 μm, 100 Å,
Thermo Fisher Scientific) was used as trap column at a flow
rate of 25 μL min−1 maintained at 45 °C. The LC separation
was followed by a cleaning cycle with an additional 15 min of
column equilibration time. Then, peptide ions were analyzed in
the full scan MS scanning mode at 35,000 MS resolution with
an automatic gain control (AGC) of 1 × 106, injection time of
200 ms, and scan range of 375−1400 m/z. The top ten most
abundant ions were selected for data-dependent MS/MS
analysis with a normalized collision energy level of 30
performed at 17,500 MS resolution with an AGC of 1 × 105
and maximum injection time of 100 ms. The isolation window
was set to 2.0 m/z, with an underfilled ratio of 0.4%, dynamic
exclusion was employed; thus, one repeat scan (i.e., two MS/
MS scans in total) was acquired in a 45 s repeat duration with
the precursor being excluded for the subsequent 45 s.
2.7. Data Analysis and Statistical Analysis
Peptide mass spectra were then searched against the
SwissProt_2019_11 database (selected for Homo sapiens,
unknown version, 20,368 entries) using the Mascot search
engine (version 2.5.1; www.matrixscience.com) for matches to
primary protein sequences. This search included the fixed
carbamidomethyl modification of cysteine as it results from
addition of DTT to proteins. Deamidation (asparagine and
glutamine) and oxidation (lysine, methionine, and proline)
were considered as variable modifications. The enzyme was set
to trypsin with a maximum of two missed cleavages allowed.
Mass tolerances for precursor and fragmented ions were set at
5 ppm and 0.5 Da, respectively. It was assumed that all spectra
hold either 2+ or 3+ charged precursors. Scaffold (version
Scaffold_4.10.0, Proteome Software Inc., Portland, OR) was
used to validate MS/MS-based peptide and protein identi-
fications. Peptide identifications were accepted if they could be
established at greater than 95.0% probability to maximize the
reliability of the identifications. Peptide Probabilities from
Mascot were assigned by the Scaffold Local FDR algorithm
and by the Peptide Prophet algorithm39 with Scaffold delta-
mass correction. Protein identifications were accepted if they
could be established at greater than 90.0% probability and
contained at least two identified peptides, in order to filter for
the most accurate matches. This resulted in having a calculated
decoy False Discovery Rate (FRD) of 0.06% for peptides and
1.9% for proteins. Protein probabilities were assigned by the
Protein Prophet algorithm.40 Proteins that contained similar
peptides and could not be differentiated based on MS/MS
analysis alone were grouped to satisfy the principles of
parsimony. Proteins sharing significant peptide evidence were
grouped into clusters. Progenesis Qi for Proteomics (version
4.1; Nonlinear Dynamics, Newcastle, U.K.) was used to
perform relative quantitation calculations using the recorded
ion intensities (area under the curve) and averaging the N
most abundant peptides for each protein (Hi−N method,
where N = 3) and protein and post-translational modification
identifications. In order to increase the reliability of the
matches, peptide ions with a score of <28, which indicates
identity or extensive homology (p < 0.05), were excluded from
the analysis based on the Mascot evaluation of the peptide
score distribution for the searched .mgf file originating from
Progenesis (combining all the samples in a single experiment).
To further improve the reliability of the findings, we
implemented an additional level of filtering, excluding proteins
with a peptide count of <2. Samples were grouped together
using the between-subject design scheme in Progenesis, in
order to compare selected groups of samples (e.g., skeletonized
vs fresh bones) and to calculate ANOVA p-values and
maximum fold changes accordingly. The use of three
extractions per targeted bone sample provided a sufficiently
large data set for comparative analysis. To identify proteins of
interest, proteins were selected that had an ANOVA p-value ≤
0.05 and a maximum fold change ≥2. Common contaminants
such as keratins were excluded from the interpretation of the
results. Plots were carried out using R version 3.6.2 with
packages dplyr, ggplot2, ggpubr, and patchwork packages.
When plotting boxplots, for data following a normal
distribution student’s t-test and one-way ANOVA and post-
hoc pairwise comparisons were used to test mean differences,
otherwise the Wilcoxon rank sum test and Kruskal Wallis test
with post-hoc pairwise comparisons were used. STRING
software version 11.0 was used to visualize functional links
between the extracted proteins.41 The confidence score
required for showing interactions was set to “high = 0.700.”
The MCL clustering method was used to identify the clusters,
with inflation parameter = 1.5.
3. RESULTS
3.1. Proteomic Data
The proteome of both the midshaft tibia and the iliac crest of
four human body donors sampled at “fresh” (PMI = 2−10
days) and at “skeletonized” (i.e., when bodies did not have any
adhering/desiccated soft tissue) stages of decomposition (PMI
variable, between ∼5200 and ∼17,800 ADD, depending on the
season of placement, see Supporting Information, Table 2) was
analyzed. Three replicate extractions were taken from each
bone, totaling 48 proteomic analyses (Supporting Information,
Table 2). After refining the Progenesis results based on the
number of unique peptides and on the ion score (see the
Methods section), 133 quantifiable proteins including bone,
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plasma, ubiquitous, muscle, and extracellular matrix proteins
were identified (Supporting Information, Data 1). The protein
interaction network (Figure 1) showed a significant enrich-
ment of interactions (PPI enrichment p < 1.0 × 10−16) and
functional enrichments of specific GO terms for biological
processes, cellular components, and molecular functions
(Supporting Information, Data 2).
3.2. Human Proteomic Inter-Skeletal and Inter-Individual
Variability
Fresh samples were found to have a significantly greater
protein diversity than skeletonized samples (Figure 2A), and,
in particular, fresh iliac samples were the richest samples
analyzed, both in terms of proteome diversity (average of 55
distinct proteins in iliac fresh samples vs 27 for tibia fresh, 15
for iliac skeletonized, and 23 for tibia skeletonized, see
Supporting Information, Data 3 for details) and protein
relative abundances (Supporting Information, Data 4). Of
note, fresh iliac samples were characterized by the presence of
73 proteins found exclusively in that sample type and not in
tibia samples (Supporting Information, Data 3). Among these,
38 are blood/serum proteins, and the remainder are bone-
specific/mineral-binding (17), extracellular matrix (1), ubiq-
uitous (13), and muscle (4) proteins. When considering
protein-relative abundances, among the 116 proteins with
significantly different relative abundances between the various
bones and sampling times (i.e., fresh vs skeletonized), 105
(90.5%) were more abundant in the fresh iliac samples, eight
(6.9%) in the skeletonized tibia samples, two (1.7%) in the
fresh tibia samples, and one (0.9%) in the skeletonized iliac
samples (Supporting Information, Data 4). When comparing
iliac fresh and skeletonized samples, 96 proteins including all
protein types [bone (29), muscle (2), ubiquitous (12),
cartilaginous (1), extracellular matrix (2), and plasma (50)
proteins] showed significantly different abundances in the two
groups; in all cases, these were more abundant in fresh than in
skeletonized samples (Figure 3 and Supporting Information,
Data 5). Comparison of the fresh and skeletonized tibia
samples revealed 23 proteins with significantly different
expression in the two groups, of which 19 were more abundant
in the fresh samples [bone (5), muscle (3), ubiquitous (3), and
plasma (8)] and four in the skeletonized samples [bone (1),
cartilaginous (1), extracellular matrix (1), and plasma (1)]
(Figure 3 and Supporting Information, Data 5).
Comparison of inter-individual proteome variability of fresh
bones only showed that samples collected from D2 had a
Figure 1. STRING protein network of the quantifiable proteins extracted from all samples. Immunoglobulin proteins (gene names IGHA1,
IGHG2, IGHG3, IGKC, and IGLC2) were not found with STRING and are not represented in the figure. The light orange ellipse represents
collagenous and collagen-binding proteins, the red one represents plasma and bone-related proteins, the yellow-green one at the top on the left side
represents ubiquitous proteins, and the light green one at the top on the right side represents some muscle proteins. Other smaller clusters
represent other types of proteins interacting less with the major clusters identified.
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Figure 2. (A) Number of proteins extracted from each sample. Samples were grouped according to the bone type. All bone types were significantly
different from each other (post-hoc pairwise Wilcoxon-test with corrections for multiple testing). Outliers are represented as pointed dots in the
plot [two outliers identified here, one for iliac fresh (sample NP14, see Supporting Information, Table 2 for details) and one for tibia iliac
skeletonized group (sample NP45, see Supporting Information, Table 2 for details)]. (B) Number of proteins extracted from fresh samples.
Samples were grouped according to the donor. None of the donors resulted in being significantly different from each other (post-hoc pairwise
Wilcoxon-test with corrections for multiple testing, p value >0.05).
Figure 3. Venn diagram to represent STRING protein networks of proteins significantly more abundant in fresh iliac samples (left) and fresh tibia
samples (right) than in their skeletonized counterparts. Proteins shared between the two categories are represented in the middle. Immunoglobulin
proteins (gene names IGHA1, IGHG2, IGHG3, IGKC, and IGLC2) were not found with STRING and are not represented in the figure. In the
iliac crest category, red cluster represents plasma proteins, yellow cluster represents collagens and bone-related proteins, and green cluster
represents ubiquitous proteins. No obvious clusters were identified for the shared proteins and for the ones belonging to the tibia category.
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richer proteome variety (average number 62 for D2 vs 34, 33,
and 35 for D1, D3, and D4, respectively), although this
difference was not statistically significant (Figure 2B). Within
D2, the iliac sample had a notably richer proteome than the
tibia sample. In particular, we found 37 proteins uniquely
expressed in D2 fresh iliac crest and nowhere else, and for
those proteins, we found enriched KEGG pathways for
complement and coagulation cascades (Benjamini p = 5.5 ×
10−6), Biocarta pathways for the classical component pathway
(Benjamini p = 1.6 × 10−2), and GO term biological processes
for platelet degranulation (Benjamini p = 3.1 × 10−6), negative
regulation of endopeptidase activity (Benjamini p = 5.5 ×
10−6), fibrinolysis (Benjamini p = 2.2 × 10−4) and complement
activation, classical pathway (Benjamini p = 5.7 × 10−3).
Looking at inter-individual protein abundance variability
(Supporting Information, Data 6), we found 41 proteins
with differences in the relative abundance among the donors.
Of these, 36 (87.8%) were more abundant in D2 and were,
respectively, bone (6), muscle (3), ubiquitous (8), extracellular
matrix (1) and plasma (18) proteins, two each in D1 (both
plasma proteins) and D4 (both bone proteins) (4.9%) and one
in D3 (cartilaginous protein) (2.4%).
3.3. Influence of Environment on Bone Proteome
Comparison of samples from different depositional environ-
ments (open pits vs shallow burials) showed no significant
differences in the number of extracted proteins (p = 0.3; Figure
4A). Comparison of the relative protein abundances in these
two groups revealed only four proteins with a different mean
abundance for the two environments (three proteins were
more abundant in shallow burials, one protein was more
abundant in open pit placements, Supporting Information,
Data 7). A test for association between the number of
recovered proteins and the season of placement found no
significant differences (p = 0.4; Figure 4B).
3.4. Potential Proteomic Biomarkers for Human PMI
Estimation
No association was found between the number of extracted
proteins and the PMI of the samples. However, significant
decreases in the abundance of collagen alpha-1(III) chain
(CO3A1; p = 0.0041), complement C9 (CO9; p = 1.9 ×
10−6), collagen alpha-2(XI) chain (COBA2; 0.00055), matrix
Gla protein (MGP; p = 5.3 × 10−5), decorin (PGS2; p =
0.045), and transthyretin (TTHY; p = 0.035) in iliac crest
(Figure 5A−F) and of complement C3 (CO3) in tibia (p =
0.0.023; Figure 5G) were observed when comparing the
protein abundances of the four skeletonized samples.
3.5. Potential Proteomic Biomarkers for Human AAD
Estimation
The relative abundance of fetuin-A was found to be negatively
associated with AAD in fresh tibia (p = 0.033) and in
skeletonized iliac samples (p = 0.013). Skeletonized tibia
samples showed lower levels for the oldest donor and higher
levels for the others, but this result was not statistically
supported (p = 0.34). Iliac fresh samples showed similar levels
in D2 and D3 and lower values for D1 and D4 (p = 0.34;
Figure 6A−D).
Significant differences in albumin abundance were found
between different donors for both fresh (p = 0.011) and
skeletonized (p = 0.016) iliac samples (Figure 6E−H). In
particular, fresh iliac samples showed a positive association
with AAD, while fresh and skeletonized tibia samples both
showed a negative relationship with AAD, although these
results were not significant [Figure 6; (p = 0.12 and 0.35,
respectively)].
Additionally, a significant increase in the abundance of
olfactomedin-like protein 3 (OLFL3) was observed in
skeletonized iliac samples with increasing AAD (Figure 6G;
p = 0.031).
Figure 4. Number of proteins extracted from skeletonized samples, grouped by (A) depositional environment or (B) placement season. No
significant differences were detected (Wilcoxon and Kruskal−Wallis p value >0.05).
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3.6. Micro Computed Tomography (μCT)
μCT was conducted on skeletonized samples with the aim to
evaluate the potential relationship between structural param-
eters and surviving proteins. The limited sample size did not
permit statistical comparison between samples, however
sample D2 showed considerably higher values for BV/TV
and BMD. For instance, these values are 0.97 for tibia and 0.96
for iliac crest in D2, while the mean values for the remaining
samples are 0.92 and 0.93 for tibia and iliac crest, respectively.
This results in increased vBMD. We cannot exclude that this
variation could be related to the increased protein variety and
abundance observed in this individual. Measured values can be
found in Supporting Information (Table 3).
4. DISCUSSION
The availability of bone samples both before and after
decomposition from the same body donors is currently very
limited. To the best of our knowledge, the present study is the
only one conducted to date that has included such samples
from controlled decomposition experiments, allowing us to
examine the effects of taphonomic processes such as diagenesis
and bioerosion on the bone protein profiles. Due to the limited
number of donors, in this study, we chose to analyze multiple
extractions from the same bones, which increases the number
of data points to model in small samples. However, when
treating each extraction from the same body donor as an
independent observation, it is important to consider potential
confounding by pseudo-replication. Pseudo-replication has
been extensively discussed in several fields,42−45 and
consequently, in this study, it is necessary to apply caution
in the interpretation of the observed results. The present work
highlights the presence of certain protein biomarkers from a
small number of donors, which could be useful for future
research on the relation between PMI and protein profiles, and
reveals how the mineral matrix and processes of bioerosion
likely play a crucial role in the survival of proteins during
decomposition. As such, this study represents an important
Figure 5. Abundance of (A) CO3A1, (B) CO9, (C) COBA2, (D) MGP, (E) PGS2, and (F) TTHY protein in iliac crest-skeletonized samples and
of (G) CO3 in tibia-skeletonized samples with increasing PMIs. Groups are significantly different from each other (ANOVA p value <0.05).
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proof of concept for the analysis of the effects of both
biological and taphonomic processes on the human bone
proteome.
In this study, we identified specific proteins that significantly
decreased with increasing PMI: complement C3 for tibia and
collagen alpha-1(III) chain, complement C9, collagen alpha-
2(XI) chain, matrix Gla protein, decorin, and transthyretin for
iliac crest. Four of the identified proteins are classified as bone
structural/functional proteins (CO3A1, COBA2, MGP, and
PGS2), and three are plasma proteins (CO3, CO9, and
TTHY). Previous work, conducted on animal proxies (pigs)
left to decompose for a maximum of 6 months,32 revealed a
similar trend of consistently decreasing protein abundances
over time but for different proteins: hemoglobins, transferrins,
triosephosphate isomerase, collagen alpha-2(V) chain, and
albumin. Both studies showed a reduction in the abundances of
plasma and ubiquitous proteins, but reduction in bone
structural/functional proteins was observed only in the current
study. It is known that certain mineral-binding proteins
(including structural ones) are susceptible to taphonomic
processes of decay and diagenesis with prolonged PMIs.46 The
difference in duration and in the depositional environment and
local climate between the pig study and the present study, and
the resulting longer exposure to taphonomic processes, could
therefore explain the different trends in mineral-binding
protein abundances reduction that we observed. Analysis of
human femoral bones from a cemetery context by Prieto-
Bonete and colleagues34 also revealed a distinct reduction in
the amount of structural and functional proteins in the highest
PMI samples (13−20 years). Among the list of proteins
identified in their study as biomarkers for prolonged PMIs,
COBA2 was the only one that was also found in our study,
showing a similar inverse association with increasing PMIs.
Overall, these findings suggest that COBA2 could be a good
candidate for PMI estimation of human skeletonized remains,
due to its durability over time and under different
taphonomical conditions.
Our study found that the abundance of OLFL3, an
osteoblast secreted extracellular matrix glycoprotein,47 was
positively associated with AAD in skeletonized iliac samples,
adding a previously unreported protein to the list of potential
biomarkers for AAD. Previous studies on animal and
archaeological human bones identified a negative correlation
between serum fetuin-A and AAD21,48 and proposed fetuin-A
as a potential biomarker for AAD.31 The present study
identified a similar negative relationship in fresh tibia and
skeletonized iliac crest samples but not in fresh iliac and
skeletonized tibia. In addition to fetuin-A, several studies
showed that serum albumin concentration is negatively
correlated with AAD.49,50 The present study found a non-
significant negative correlation both in fresh and skeletonized
tibia samples but an opposite and significant trend in fresh iliac
Figure 6. Relative abundance of fetuin-A in (A) fresh tibia, (B) skeletonized tibia, (C) fresh iliac crest, and (D) skeletonized iliac crest samples, of
albumin in (E) fresh tibia, (F) skeletonized tibia, (G) fresh iliac crest, and (H) skeletonized iliac crest samples and of (I) olfactomedin like-3 in
skeletonized iliac crest samples, arranged by the chronological age of the donors. ANOVA p value was reported for each plot. Only (A,D,G,H,I)
resulted in being statistically significant.
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samples. Considering the relatively small sample size, it is
difficult to interpret these findings. Our results therefore
represent a proof of concept for further research involving a
larger sample size that might clarify whether fetuin-A and
albumin are consistently negatively correlated with AAD in
humans in different bone types and therefore could be used as
a biomarker for AAD.
BMD is known to vary between different parts of the
skeleton,51 and iliac bone is generally less densely mineralized
than tibia. In our skeletonized samples, the iliac crest showed
lower BMD than tibia in three out of four individuals. D3 was
the only donor that showed a slightly higher BMD for iliac
crest than for tibia. The highly vascularized (e.g., supplied with
blood vessels) and less densely mineralized fresh iliac samples
yielded greater variety and abundance of proteins, particularly
of those expressed specifically in plasma. The proteomes
recovered from skeletonized iliac samples demonstrated that
significant protein decay occurred in this bone. The denser and
less porotic fresh tibia samples yielded lower protein variety
and abundances by comparison to the fresh iliac samples.
Comparison of the fresh tibia samples with the skeletonized
tibia samples showed that protein decay also occurred in this
bone but not to the degree observed in the iliac crest. These
results suggest that natural differences in BMD and blood
perfusion between the iliac crest and the midshaft anterior tibia
influence both the in vivo protein variety and abundance as well
as the preservation of the bone proteome throughout the
taphonomic processes of decomposition. A combination
between higher vascularization of the iliac crest and lower
BMD exposed this bone to significant deterioration as a result
of taphonomic processes over time, resulting in the limited
inter-individual differences observed in the skeletonized iliac
samples. Protein extraction from the dense anterior midshaft
tibia indicated less taphonomic deterioration over time with
mineral-binding and bone-associated proteins less prone to
deterioration in skeletonized tibia in comparison with
skeletonized iliac crest. While taphonomic processes of
decomposition are known to affect BMD in humans, and can
differentially affect skeletal elements,52,53 our results suggest
that higher initial (natural) BMD may have a protective effect
on proteins within the mineral matrix. BMD could theoretically
affect the variety and abundance of specific non-collagenous
proteins that can either bind to the calcium ions or the
collagen in the mineral matrix,26 thereby affecting the overall
protein profile.
The potentially protective environment of the bone mineral
matrix for specific proteins may be related to the effects of the
decomposer community and physicochemical environment on
the decomposition of human remains. A less dense matrix
would facilitate leaching while promoting the movement of
decomposer microbes throughout the bone. Microbial-induced
bioerosion, which is characterized by the chemical dissolution
of mineral components of bone followed by the microbial
enzymatic attack of organic components of bone, is thought to
be one of the main causes of bone diagenesis.54 The movement
of decomposer microbes might be restricted to the external
surfaces of more densely mineralized bone. The effects of the
decomposer microbial community may be further influenced
by the location of the bones. The position of the iliac crest in
the trunk of the body exposes this bone to the moisture and a
large gastrointestinal microbial community of the gut, which is
known to translocate during decomposition.55,56 The iliac
crest, therefore, is located in a microhabitat that is more
favorable for microbial decomposition. In contrast, the tibia is
located further from the trunk in limbs that are more prone to
desiccation during decomposition. The body position during
decomposition of the four donors was flexed and allowed the
anterior tibiae to remain elevated above decomposition fluids
excreted from the trunk. Desiccation of the soft tissues around
the anterior tibiae was observed early on during decomposition
of both open pit placements. Desiccated, densely mineralized
bone is unlikely to be favorable for microbial decomposition.
Inter-individual comparisons revealed that fresh tibia
samples from all four donors had greater inter-individual
reproducibility than fresh iliac samples, whereas fresh iliac
samples among different individuals were less reproducible,
being characterized by an increased abundance and variety of
serum proteins as previously reported. However, this
phenomenon was exacerbated particularly in D2, the donor
showing the highest BMD measurements for both anatomical
areas. The enrichment pathways observed for the proteins
uniquely present in D2 fresh iliac crest showed processes of
inflammation and coagulation that could be related with the
carcinogenic history of the donor and with potential metastasis
originating in close proximity (i.e., iliac crest) to the carcinoid
tumor. Moreover, the presence of specific proteins such as
granins suggests a neuroendocrine origin of the tumor, which
appears to be associated with the carcinoid tumor that this
donor had. The available medical information on D2 suggests
that certain conditions and treatments received in the years
prior to death could have been associated with changes in
BMD, including chemotherapy treatment for cancer, pro-
longed consumption of calcium lactate,57 and possible use of
probiotics as adjuvant during cancer treatment.58,59 While no
conclusive interpretation can be drawn regarding the relation-
ship between increased BMD and medical history for this
specific cohort, these results indicate that it is important to
consider that medical treatments could induce physicochem-
ical and structural modifications of bone matrix that could
affect PMI estimation based on proteomics. Similarly, this
concept can be extended to metabolic disorders that
significantly affect bone matrix and that are exacerbated with
increasing age such as osteoporosis.60
The greater BMD of D2 may have allowed for a stronger in
vivo embedding of mineral-binding and bone-related proteins
within the mineral matrix, resulting in the greater proteomic
variety of this class of proteins, in addition to the previously
discussed blood proteins, particularly in D2 fresh iliac samples.
This effect of BMD on protein linkage in bones may be
explained in a similar way to what is normally observed
between organic matter content and soil density (which is
often a function of clay content), where a positive relationship
exists between the two variables. In fact, clay particles tend to
carry a negative charge to bind with nutrient cations such as
calcium and potassium, and these bonds can protect proteins
from decomposition and even from extreme environmental
conditions such as autoclaving.61
Comparison of samples from open pit placements with
samples from burials, as well as comparison of season of
placement in this study, found no significant differences. While
analyses of archaeological remains have revealed differences in
protein recovery related to depositional environment,23,26,33 it
is possible that due to the relatively short duration of this
experiment, such environmental effects were not measurable in
this study. It is also possible that the two depositional
environments did not produce distinct enough conditions
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(Supporting Information, Table 1) to cause noticeable
differences in the preservation of the biomolecules.
The preliminary indications from this study support previous
findings that specific proteins decay at different rates,
strengthening the potential for developing bone proteomic
PMI estimation methods. COBA2 appears to be a good
candidate for PMI estimation of skeletonized remains, together
with CO3A1, PGS2, and MGP. The blood proteins CO3,
CO9, and TTHY may be good candidates for shorter PMI
estimation (i.e., before the complete degradation of blood
proteins). Our study only partially supported previous studies
identifying fetuin-A and albumin as potential biomarkers for
AAD estimation, and additionally found OLFL3 being
positively correlated with AAD.
At the same time, our findings suggest that taphonomic (e.g.,
microbial bioerosion) and biological (e.g., variation in BMD
and perfusion) variables play a significant role in the survival of
proteins. While the sample size is relatively small, the findings
point toward potentially significant effects of inter-individual
variation associated with health conditions and medical
treatment on the variety and abundance of recovered proteins.
The results of both inter-individual and intra-skeletal
comparisons in our study also suggest that higher BMD may
promote attachment of a greater abundance and variety of
mineral-binding proteins. Intra-skeletal differences in BMD
appear to lead to distinct differences in the variety and
abundance of preserved (and extracted) proteins. The
attachment of proteins within a more densely mineralized
bone matrix may protect them during microbial bioerosion and
diagenesis. Based on these indications, we recommend
including standard measurement of BMD and targeting a
combination of different biomarkers (i.e., abundances of
selected plasma proteins and bone-specific proteins) in future
work. Overall, our results emphasize the limitations of
developing methods and models based on animal proxies
since farmed animals rarely show the degree of inter-individual
dietary activity and disease-related variation that humans do,
and BMD and degree of perfusion of bones differ between
species.62 Moreover, these results emphasize the importance of
conducting replication studies in larger human samples,
representing a broader range of robust biomarkers for PMIs
and AAD, as well as sampling different bones, to better
understand how different types of proteins and different parts
of the human skeleton are affected by biological variations and
taphonomic processes and to build and validate predictive
models for PMI and AAD estimation.
Finally, preliminary evaluation of the inter-skeletal differ-
ences we observed suggests that for future development of
proteomic PMI estimation methods, the iliac crest bone may
be a more suitable sampling target for relatively fresh remains
of forensic interest and for archaeological studies specifically
targeting the serum-proteins, due to the presence of greater
protein variety of bone-marrow proteins. Specific burial
conditions, such as dry burial environments, anaerobic
environments, and certain post-mortem treatments of the
body (such as embalming procedures) can limit the amount of
bone diagenesis,63,64 thereby promoting the survival of bone
proteins across archaeological timeframes. In such circum-
stances, the iliac crest may provide better results than the tibia
to detect pathologies and infections associated with the bone
marrow. The midshaft tibia may be a more suitable sampling
target for skeletonized remains or those in a state of advanced
decomposition, due to the better survival of collagen and
mineral-related proteins that could be ultimately used for
developing new biomolecular methods for PMI/AAD
estimation for forensic purposes.
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